1. Home
  2. LTRN vs EVGN Comparison

LTRN vs EVGN Comparison

Compare LTRN & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$0.65

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo Evogene Ltd

EVGN

Evogene Ltd

N/A

Current Price

$0.38

Market Cap

11.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
LTRN
EVGN
Founded
2013
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
11.1M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
LTRN
EVGN
Price
$0.65
$0.38
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $17.50
N/A
AVG Volume (30 Days)
★ 263.4K
113.7K
Earning Date
11-12-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 18.65
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$81.06
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.35
52 Week High
$4.34
$1.28

Technical Indicators

Market Signals
Indicator
LTRN
EVGN
Relative Strength Index (RSI) 31.02 43.02
Support Level $0.59 $0.36
Resistance Level $1.96 $0.41
Average True Range (ATR) 0.09 0.02
MACD 0.05 0.00
Stochastic Oscillator 24.02 53.55

Price Performance

Historical Comparison
LTRN
EVGN

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: